This meeting took place in 2004

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

HIV Vaccine Development: Progress and Prospects (X8)

Organizer(s) Norman L. Letvin, Nina Bhardwaj and Barney S. Graham
April 12—18, 2004
Whistler Conference Centre • Whistler, British Columbia Canada
Abstract Deadline: Dec 11, 2003
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Feb 12, 2004

Sponsored by Wyeth Vaccines Research

Summary of Meeting:
The magnitude of the world-wide public health problem posed by HIV is well known. Control of the AIDS epidemic will only come with the development of a successful vaccine. The potential efficacy of both cellular and humoral immune responses in controlling HIV replication is now well documented. However, the ability of the virus to mutate away from recognition by T lymphocytes and neutralizing antibody continues to frustrate attempts to make a successful vaccine. A number of recent observations have dramatically increased the optimism of those involved in HIV vaccine development. It is now clear that vaccine-elicited cellular immune responses can contribute to containing the level of viral replication and delay the progression of clinical disease following an AIDS virus infection in nonhuman primates. It has also recently been shown that monoclonal antibodies that neutralize a diversity of HIV isolates can protect against HIV infection of nonhuman primates when passively administered to animals prior to challenge. Finally, a number of novel vaccine strategies are showing promise in early clinical trials in eliciting relevant immune responses in human volunteers. A meeting on HIV vaccines in 2004 will be extremely timely, in that data from large scale human trials of promising vaccine candidates will be available at that time for presentation. A number of early phase trials with a newer generation of vaccine candidates will also just be initiated and data will be available from those trials. Finally, new data from basic immunology and AIDS immunopathogenesis studies will be available for presentations that bear on the creation of new strategies for HIV vaccination. The Keystone HIV Vaccine Meeting has become recognized as the most important forum for presenting new data in this important area of research. The meeting is attended annually by the most important investigators in the field worldwide. There is every reason to suppose that this will continue to be the case.

View Meeting Program


Scholarship / Award Information

Scholarship Deadline: (11:59 PM US Mountain Standard Time)
*All deadlines end at 11:59 PM US Mountain Standard Time
NOTE: Please use the button above to Apply for a Scholarship


Keystone Symposia is offering scholarships of up to 1,200 USD to Students and Postdoctoral fellows. These scholarships are to be used to help defray the expenses associated with conference attendance, including airfare (restrictions may apply based on funding source), ground transportation, lodging costs, and a portion of meeting registration. Receipts will be required to receive reimbursement.

Abstracts submitted for poster presentation will be used as the basis for awarding the scholarships. Scholarship recipients will be selected based on the quality of science of the abstract and the relevance of the abstract to the conference topic. Only one application per abstract is accepted. Only one award per lab will be allocated.


To be eligible for a scholarship, you must be:

A graduate student or postdoctoral fellow currently enrolled in an academic institute at the start of the meeting for which you are applying. Note: a graduate student is defined as a student who is studying for a higher degree at an academic institution. A postdoctoral fellow is defined as an individual with a Ph.D., M.D., or DVM degree who is engaged in a temporary period of mentored research and/or scholarly training for the purpose of acquiring the professional skills needed to pursue their desired career path, and is within 6 years of these degrees.

Review Criteria

Criteria for Abstract Review:

  1. Relevance to the meeting topic
  2. Significance of the scientific question and results
  3. Style
    • Organization (e.g. the abstract has a clear beginning, middle and end)
    • Grammar and spelling
  4. Clarity of scientific presentations
    • Clear question or hypothesis
    • Sufficient background
    • The experimental approach and rationale for the approach are clear
    • The results are clearly presented
    • The interpretation and conclusions are reasonable and logical

Application Process

If you are eligible and wish to be considered for a scholarship, you should complete all of the following by the scholarship deadline for the meeting you wish to attend. It is recommended you begin these steps in advance of the deadline date to ensure completion.

Click here to start a scholarship application.

  See the Scholarship FAQ's

Underrepresented Trainee Scholarships are also available...
Please Click Here for more information about Underrepresented Trainee Scholarship.

  See the Underrepresented Trainee Scholarship FAQ's

If you have any questions, please contact